La Reina schreef op 13 augustus 2020 13:48:
We hadden het toch over Biocryst? En over CFO Doyle? De man heeft enorm vertrouwen in zijn company.....Laatste nieuws:
BioCryst Pharma +5% as CFO buys $220,000 worth
Aug. 12, 2020 5:57 PM ET|About: BioCryst Pharmaceuticals, ... (BCRX)|By: Jason Aycock, SA News Editor
BioCryst Pharmaceuticals (NASDAQ:BCRX) is up 5% postmarket after disclosing that Chief Financial Officer Anthony Doyle bought 54,000 shares.
Doyle bought the shares yesterday at an average price of $4.08, leading to an outlay of just over $220,000.
That amounts to the total of his beneficial ownership. Doyle was named to the CFO post in early April.seekingalpha.com/news/3604911-biocrys...